comparemela.com
Home
Live Updates
Cadrenal Therapeutics to Participate in a Fireside Chat at t
Cadrenal Therapeutics to Participate in a Fireside Chat at t
Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
PONTE VEDRA, Fla., Jan. 24, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant designed to...
Related Keywords
Douglas Losordo ,
Robert Blum ,
Matthew Szot ,
Joe Pantginis ,
Prnewswire Cadrenal Therapeutics Inc ,
Cadrenal Therapeutics Inc ,
Company Webcast ,
Nasdaq ,
Hc Wainwright Co ,
Lytham Partners ,
Chief Medical Officer ,
Managing Director ,
Vitamink Antagonist ,
Markets ,